–
Janux Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.9
FY22:
−67.1
FY23:
−73.0
FY24:
−98.8
FY25:
−158
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.8
FY22:
−66.3
FY23:
−71.0
FY24:
−96.8
FY25:
−156
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.7
FY22:
−63.1
FY23:
−58.3
FY24:
−69.0
FY25:
−114
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.7
FY22:
−63.1
FY23:
−58.3
FY24:
−69.0
FY25:
−114
All amounts in millions USD